The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
HLA-E Surface Expression Depends on Binding of TAP-Dependent Peptides Derived from Certain HLA Class I Signal Sequences
Abstract
Previous studies showed that HLA-E was expressed in lymphoblastoid cell line (LCL) 721.221 cells, but surface expression was lacking. To determine the signals controlling surface expression, we constructed a series of hybrid genes using complementary portions derived from the HLA-E and HLA-A2 genes. In this manner, a hybrid of HLA-E was identified, designated AEH, which differed from HLA-E by having the HLA-A2 signal sequence substituting for the HLA-E leader peptide. Transfection of LCL 721.221 cells with AEH induced HLA-E surface expression. Analysis of peptides bound to HLA-E revealed that a nonamer peptide derived from the A2 signal sequence was the predominant peptide bound. LCL 721.221 cells transfected with certain class I genes, including HLA-G, were also sufficient to promote peptide binding and HLA-E surface expression without increasing the level of HLA-E heavy chain synthesis. Peptides bound to HLA-E consisted of nine amino acids, with methionine at position 2 and leucine in the carboxyl-terminal position, and were nearly identical to the leader sequence-derived peptide previously shown to be a predominant peptide bound to the murine Qa-1 Ag. Signal peptides derived from certain HLA-B proteins with threonine in position 2 only marginally up-regulated HLA-E surface expression in .221 cells. An examination of HLA-E peptide binding in the TAP negative cell line .134 indicated that peptide binding to HLA-E was dependent on a functional TAP heterodimer regardless of whether peptide was available in cis, as in the AEH construct, or in trans, as in the class I transfectants of .221 cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
[2] New M13 vectors for cloning
Messing, J. (1983) · Methods in Enzymology · doi:10.1016/0076-6879(83)01005-8 · Cited by 5,323
Roepstorff, P., & Fohlman, J. (1984) · Biological Mass Spectrometry · doi:10.1002/bms.1200111109 · Cited by 2,633
A Class I Antigen, HLA-G, Expressed in Human Trophoblasts
Kovats, S., Main, E. K., Librach, C., Stubblebine, M., Fisher, S. J., & DeMars, R. (1990) · Science · doi:10.1126/science.2326636 · Cited by 1,407
Protein sequencing by tandem mass spectrometry.
Hunt, D. F., Yates, J. R., Shabanowitz, J., Winston, S., & Hauer, C. R. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.17.6233 · Cited by 1,180
Major histocompatibility antigens: The human (HLA-A,-B,-C) and murine (H-2K, H-2D) class I molecules
Ploegh, H. L., Orr, H. T., & Strominger, J. L. (1981) · Cell · doi:10.1016/0092-8674(81)90318-4 · Cited by 520
Protection from Natural Killer Cell-Mediated Lysis by HLA-G Expression on Target Cells
Pazmany, L., Mandelboim, O., Valés-Gómez, M., Davis, D. M., Reyburn, H. T., & Strominger, J. L. (1996) · Science · doi:10.1126/science.274.5288.792 · Cited by 497
HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides
Wei, M. L., & Cresswell, P. (1992) · Nature · doi:10.1038/356443a0 · Cited by 496
Spies, T., & DeMars, R. (1991) · Nature · doi:10.1038/351323a0 · Cited by 406
Pende, D., Biassoni, R., Cantoni, C., Verdiani, S., Falco, M., di Donato, C., Accame, L., Bottino, C., Moretta, A., & Moretta, L. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.505 · Cited by 365
A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4.
Fujii, T., Ishitani, A., & Geraghty, D. E. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.12.5516 · Cited by 362
Self-citation
Cited by
Lanier, L. L. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115526 · Cited by 2,769
Mass Spectrometry in Proteomics
Aebersold, R., & Goodlett, D. R. (2001) · Chemical Reviews · doi:10.1021/cr990076h · Cited by 1,238
Self-citationSelection of evolutionarily conserved mucosal-associated invariant T cells by MR1
Treiner, E., Duban, L., Bahram, S., Radosavljevic, M., Wanner, V., Tilloy, F., Affaticati, P., Gilfillan, S., & Lantz, O. (2003) · Nature · doi:10.1038/nature01433 · Cited by 1,139
Spaggiari, G. M., Capobianco, A., Becchetti, S., Mingari, M. C., & Moretta, L. (2006) · Blood · doi:10.1182/blood-2005-07-2775 · Cited by 1,067
HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
Lee, N., Llano, M., Carretero, M., Ishitani, A., Navarro, F., López-Botet, M., & Geraghty, D. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5199 · Cited by 1,053
Self-citationKIR: Diverse, Rapidly Evolving Receptors of Innate and Adaptive Immunity
Vilches, C., & Parham, P. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.092501.134942 · Cited by 986
REGULATION OF IMMUNE RESPONSES THROUGH INHIBITORY RECEPTORS
Long, E. O. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.875 · Cited by 939
Rajagopalan, S., & Long, E. O. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.7.1093 · Cited by 726
Characterization of the expression of MHC proteins in human embryonic stem cells
Drukker, M., Katz, G., Urbach, A., Schuldiner, M., Markel, G., Itskovitz-Eldor, J., Reubinoff, B., Mandelboim, O., & Benvenisty, N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142298299 · Cited by 671
Tomasec, P., Braud, V. M., Rickards, C., Powell, M. B., McSharry, B. P., Gadola, S., Cerundolo, V., Borysiewicz, L. K., McMichael, A. J., & Wilkinson, G. W. G. (2000) · Science · doi:10.1126/science.287.5455.1031 · Cited by 661
Association of DAP12 with Activating CD94/NKG2C NK Cell Receptors
Lanier, L. L., Corliss, B., Wu, J., & Phillips, J. H. (1998) · Immunity · doi:10.1016/s1074-7613(00)80574-9 · Cited by 559
Activating and inhibitory receptors of natural killer cells
Pegram, H. J., Andrews, D. M., Smyth, M. J., Darcy, P. K., & Kershaw, M. H. (2011) · Immunology & Cell Biology · doi:10.1038/icb.2010.78 · Cited by 555
HLA‐G and immune tolerance in pregnancy
Hunt, J. S., Petroff, M. G., McIntire, R. H., & Ober, C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2078rev · Cited by 524
Vance, R. E., Kraft, J. R., Altman, J. D., Jensen, P. E., & Raulet, D. H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.10.1841 · Cited by 482
Vales-Gomez, M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.15.4250 · Cited by 384
Llano, M., Lee, N., Navarro, F., García, P., Albar, J. P., Geraghty, D. E., & López-Botet, M. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199809)28:09<2854::aid-immu2854>3.0.co;2-w · Cited by 382
Self-citationIshitani, A., Sageshima, N., Lee, N., Dorofeeva, N., Hatake, K., Marquardt, H., & Geraghty, D. E. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.3.1376 · Cited by 377
Self-citationHLA-G Molecules: from Maternal–Fetal Tolerance to Tissue Acceptance
CAROSELLA, E. D., MOREAU, P., LE MAOULT, J., LE DISCORDE, M., DAUSSET, J., & ROUAS-FREISS, N. (2003) · Advances in Immunology · doi:10.1016/s0065-2776(03)81006-4 · Cited by 371
Navarro, F., Llano, M., Bellón, T., Colonna, M., Geraghty, D. E., & López-Botet, M. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199901)29:01<277::aid-immu277>3.0.co;2-4 · Cited by 366
Self-citationGeneration of hypoimmunogenic human pluripotent stem cells
Han, X., Wang, M., Duan, S., Franco, P. J., Kenty, J. H.-R., Hedrick, P., Xia, Y., Allen, A., Ferreira, L. M. R., Strominger, J. L., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1902566116 · Cited by 363
Beyond the increasing complexity of the immunomodulatory HLA-G molecule
Carosella, E. D., Favier, B., Rouas-Freiss, N., Moreau, P., & LeMaoult, J. (2008) · Blood · doi:10.1182/blood-2007-12-127662 · Cited by 348
MHC class Ib molecules bridge innate and acquired immunity
Rodgers, J. R., & Cook, R. G. (2005) · Nature Reviews Immunology · doi:10.1038/nri1635 · Cited by 323
Reprogramming of CTLs into natural killer–like cells in celiac disease
Meresse, B., Curran, S. A., Ciszewski, C., Orbelyan, G., Setty, M., Bhagat, G., Lee, L., Tretiakova, M., Semrad, C., Kistner, E., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060028 · Cited by 322
Self-citationUlbrecht, M., Martinozzi, S., Grzeschik, M., Hengel, H., Ellwart, J. W., Pla, M., & Weiss, E. H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.5019 · Cited by 310
Strong, R. K., Holmes, M. A., Li, P., Braun, L., Lee, N., & Geraghty, D. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208268200 · Cited by 308
Self-citationYokoyama, W. M. (1995) · Current Opinion in Immunology · doi:10.1016/0952-7915(95)80036-0 · Cited by 299
Monalizumab: inhibiting the novel immune checkpoint NKG2A
van Hall, T., André, P., Horowitz, A., Ruan, D. F., Borst, L., Zerbib, R., Narni-Mancinelli, E., van der Burg, S. H., & Vivier, E. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0761-3 · Cited by 292
Broadly targeted CD8 + T cell responses restricted by major histocompatibility complex E
Hansen, S. G., Wu, H. L., Burwitz, B. J., Hughes, C. M., Hammond, K. B., Ventura, A. B., Reed, J. S., Gilbride, R. M., Ainslie, E., Morrow, D. W., et al. (2016) · Science · doi:10.1126/science.aac9475 · Cited by 290
HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C
Thomas, R., Apps, R., Qi, Y., Gao, X., Male, V., O'hUigin, C., O'Connor, G., Ge, D., Fellay, J., Martin, J. N., et al. (2009) · Nature Genetics · doi:10.1038/ng.486 · Cited by 283
Evolutionarily Conserved Amino Acids That Control TCR-MHC Interaction
Marrack, P., Scott-Browne, J. P., Dai, S., Gapin, L., & Kappler, J. W. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090421 · Cited by 269
Chiesa, M. D., Vitale, M., Carlomagno, S., Ferlazzo, G., Moretta, L., & Moretta, A. (2003) · European Journal of Immunology · doi:10.1002/eji.200323986 · Cited by 258
Human Cytomegalovirus Drives Epigenetic Imprinting of the IFNG Locus in NKG2Chi Natural Killer Cells
Luetke-Eversloh, M., Hammer, Q., Durek, P., Nordström, K., Gasparoni, G., Pink, M., Hamann, A., Walter, J., Chang, H.-D., Dong, J., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004441 · Cited by 256
Jinushi, M., Takehara, T., Tatsumi, T., Kanto, T., Miyagi, T., Suzuki, T., Kanazawa, Y., Hiramatsu, N., & Hayashi, N. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.10.6072 · Cited by 228
The role of / T cells in the feto-maternal relationship
Szekeres-Bartho, J., Barakonyi, A., Miko, E., Polgar, B., & Palkovics, T. (2001) · Seminars in Immunology · doi:10.1006/smim.2000.0318 · Cited by 85
Moro-García, M. A., Fernández-García, B., Echeverría, A., Rodríguez-Alonso, M., Suárez-García, F. M., Solano-Jaurrieta, J. J., López-Larrea, C., & Alonso-Arias, R. (2014) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.12.014 · Cited by 64
Metadata
- Authors
- Lee, N., Goodlett, D. R., Ishitani, A., Marquardt, H., & Geraghty, D. E.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-05
- Volume
- 160
- Issue
- 10
- Pages
- 4951-4960
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1906987668
- Cited by
- 505
- References
- 32
- FWCI
- 10.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.